Dunbar Pharma has been featured in the Business Post, highlighting the company’s continued international expansion and plans for the UK and German pharmaceutical markets.
The article explores Dunbar Pharma’s growth from its manufacturing base in Athlone and the company’s move into key European markets for pharmaceutical-grade cannabinoid medicines.
This international expansion represents an important milestone for Dunbar Pharma as we continue to build reliable pharmaceutical infrastructure for plant-derived cannabinoid medicines and strengthen access to high-quality, EU GMP-manufactured dronabinol.
Read the full article in the Business Post:
Roscommon cannabinoid processor Dunbar Pharma plans UK and German market entry →
Media Contact
For further information, please contact:
Nicole Farah
Americana Communications Ltd.
pr@dunbarpharma.ie
www.americanapr.com
About Dunbar Pharma
Dunbar Pharmaceuticals (Mercury Rising Ltd.) is a privately owned Irish pharmaceutical manufacturer and Ireland’s first EU GMP manufacturer of plant-derived cannabinoid active pharmaceutical ingredients (APIs). Based in Athlone, Ireland, the company manufactures difficult-to-make, pharmaceutical-grade APIs, including plant-derived dronabinol, to recognised pharmacopoeia standards for regulated pharmaceutical markets, including Germany and the UK.
Built from the ground up as a pharmaceutical manufacturer on Ireland’s world-class pharma platform, Dunbar Pharma operates under the oversight of the Health Products Regulatory Authority (HPRA), with validated processes and full batch traceability supporting dependable supply to licensed partners across Europe.
Dunbar Pharma was founded on a simple observation: medical use of cannabinoids was growing worldwide, but the pharmaceutical infrastructure behind it had not kept pace. The company is closing that gap, building Europe’s pharmaceutical infrastructure for plant-derived cannabinoid medicines by combining EU GMP manufacturing, pharmaceutical quality standards and reliable supply for healthcare partners and patients. The company has been recognised for its growth and innovation, including Emerging Company of the Year at the BioPharmaChem Impact Awards 2026, Product & Manufacturing Start-Up of the Year at the National Start-Up Awards 2025, and the Ambition & Growth Award at the Local Enterprise Office Awards 2026. Keep up to date on activity from Dunbar Pharma on LinkedIn.
Notes to Editor
Dunbar Pharmaceuticals (Mercury Rising Ltd.) is an Irish GMP manufacturer based in Athlone, Ireland. GMP Certificate: 35486/ASR13213/000001; ASR Certificate: ASR13213/000001 — verifiable on the EudraGMDP public register.
Dronabinol is the INN (international non-proprietary name) for delta-9-THC in purified pharmaceutical form, prescribed internationally for decades in regulated prescription medicines for specific indications.
Dunbar’s dronabinol is manufactured exclusively for pharmaceutical use, not consumer or wellness products.